1
|
Ali M, He Y, Chang ASN, Wu A, Liu J, Cao Y, Mohammad Y, Popat A, Walsh L, Ye Q, Xu C, Kumeria T. Osteoimmune-modulating and BMP-2-eluting anodised 3D printed titanium for accelerated bone regeneration. J Mater Chem B 2023; 12:97-111. [PMID: 37842835 DOI: 10.1039/d3tb01029e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2023]
Abstract
3D printing of titanium (Ti) metal has potential to transform the field of personalised orthopaedics and dental implants. However, the impacts of controlled surface topographical features of 3D printed Ti implants on their interactions with the cellular microenvironment and incorporation of biological growth factors, which are critical in guiding the integration of implants with bone, are not well studied. In the present study, we explore the role of surface topological features of 3D printed Ti implants using an anodised titania nanotube (TiNT) surface layer in guiding their immune cell interaction and ability to deliver bioactive form of growth factors. TiNT layers with precisely controlled pore diameter (between 21and 130 nm) were anodically grown on 3D printed Ti surfaces to impart a nano-micro rough topology. Immune biomarker profiles at gene and protein levels show that anodised 3D Ti surfaces with smaller pores resulted in classical activation of macrophages (M1-like), while larger pores (i.e., >100 nm) promoted alternate activation of macrophages (M2-like). The in vitro bone mineralisation studies using the conditioned media from the immunomodulatory studies elucidate a clear impact of pore diameter on bone mineralisation. The tubular structure of TiNTs was utilised as a container to incorporate recombinant human bone morphogenetic protein-2 (BMP-2) in the presence of various sugar and polymeric cryoprotectants. Sucrose offered the most sustainable release of preserved BMP-2 from TiNTs. Downstream effects of released BMP-2 on macrophages as well as bone mineralisation were assessed showing bioactivity retention of the released rhBMP-2. Overall, the TiNT surface topography in combination with controlled, sustained, and local release of bioactive growth factors can potentially enhance the osseointegration outcomes of custom 3D printed Ti implants in the clinic.
Collapse
Affiliation(s)
- Masood Ali
- Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD 4102, Australia
| | - Yan He
- Institute of Regenerative and Translational Medicine, Wuhan University of Science and Technology, Wuhan 430040, China
| | - Anna Sze Ni Chang
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
| | - Alice Wu
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
| | - Jingyu Liu
- School of Mechanical, Medical and process Engineering, Queensland University of Technology, Brisbane, Queensland 4000, Australia
| | - Yuxue Cao
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
| | - Yousuf Mohammad
- Therapeutics Research Group, Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane, QLD 4102, Australia
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
| | - Amirali Popat
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
| | - Laurie Walsh
- School of Dentistry, The University of Queensland, Herston, Queensland 4006, Australia.
| | - Qingsong Ye
- Centre of Regenerative Medicine, Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
| | - Chun Xu
- School of Dentistry, The University of Queensland, Herston, Queensland 4006, Australia.
| | - Tushar Kumeria
- School of Pharmacy, The University of Queensland, Brisbane, Queensland 4102, Australia.
- School of Materials Science and Engineering, University of New South Wales, Kensington, Sydney, New South Wales 2052, Australia
| |
Collapse
|
2
|
Rifai A, Weerasinghe DK, Tilaye GA, Nisbet D, Hodge JM, Pasco JA, Williams LJ, Samarasinghe RM, Williams RJ. Biofabrication of functional bone tissue: defining tissue-engineered scaffolds from nature. Front Bioeng Biotechnol 2023; 11:1185841. [PMID: 37614632 PMCID: PMC10444209 DOI: 10.3389/fbioe.2023.1185841] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Accepted: 07/24/2023] [Indexed: 08/25/2023] Open
Abstract
Damage to bone leads to pain and loss of movement in the musculoskeletal system. Although bone can regenerate, sometimes it is damaged beyond its innate capacity. Research interest is increasingly turning to tissue engineering (TE) processes to provide a clinical solution for bone defects. Despite the increasing biomimicry of tissue-engineered scaffolds, significant gaps remain in creating the complex bone substitutes, which include the biochemical and physical conditions required to recapitulate bone cells' natural growth, differentiation and maturation. Combining advanced biomaterials with new additive manufacturing technologies allows the development of 3D tissue, capable of forming cell aggregates and organoids based on natural and stimulated cues. Here, we provide an overview of the structure and mechanical properties of natural bone, the role of bone cells, the remodelling process, cytokines and signalling pathways, causes of bone defects and typical treatments and new TE strategies. We highlight processes of selecting biomaterials, cells and growth factors. Finally, we discuss innovative tissue-engineered models that have physiological and anatomical relevance for cancer treatments, injectable stimuli gels, and other therapeutic drug delivery systems. We also review current challenges and prospects of bone TE. Overall, this review serves as guide to understand and develop better tissue-engineered bone designs.
Collapse
Affiliation(s)
- Aaqil Rifai
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
| | - D. Kavindi Weerasinghe
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
| | - Gebreselassie Addisu Tilaye
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
| | - David Nisbet
- The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC, Australia
- Department of Biomedical Engineering, Faculty of Engineering and Information Technology, The University of Melbourne, Melbourne, VIC, Australia
- Melbourne Medical School, Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, VIC, Australia
- Laboratory of Advanced Biomaterials, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
- Aikenhead Centre for Medical Discovery, St. Vincent’s Hospital, Melbourne, VIC, Australia
| | - Jason M. Hodge
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
- Barwon Health, Geelong, VIC, Australia
| | - Julie A. Pasco
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
- Barwon Health, Geelong, VIC, Australia
- Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia
- Department of Medicine-Western Health, The University of Melbourne, St Albans, VIC, Australia
| | - Lana J. Williams
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
- Barwon Health, Geelong, VIC, Australia
| | - Rasika M. Samarasinghe
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
| | - Richard J. Williams
- Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, VIC, Australia
- The Graeme Clark Institute, The University of Melbourne, Melbourne, VIC, Australia
- Aikenhead Centre for Medical Discovery, St. Vincent’s Hospital, Melbourne, VIC, Australia
| |
Collapse
|
3
|
Terranova ML. Key Challenges in Diamond Coating of Titanium Implants: Current Status and Future Prospects. Biomedicines 2022; 10:biomedicines10123149. [PMID: 36551907 PMCID: PMC9775193 DOI: 10.3390/biomedicines10123149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Revised: 11/26/2022] [Accepted: 11/28/2022] [Indexed: 12/12/2022] Open
Abstract
Over past years, the fabrication of Ti-based permanent implants for fracture fixation, joint replacement and bone or tooth substitution, has become a routine task. However, it has been found that some degradation phenomena occurring on the Ti surface limits the life or the efficiency of the artificial constructs. The task of avoiding such adverse effects, to prevent microbial colonization and to accelerate osteointegration, is being faced by a variety of approaches in order to adapt Ti surfaces to the needs of osseous tissues. Among the large set of biocompatible materials proposed as an interface between Ti and the hosting tissue, diamond has been proven to offer bioactive and mechanical properties able to match the specific requirements of osteoblasts. Advances in material science and implant engineering are now enabling us to produce micro- or nano-crystalline diamond coatings on a variety of differently shaped Ti constructs. The aim of this paper is to provide an overview of the research currently ongoing in the field of diamond-coated orthopedic Ti implants and to examine the evolution of the concepts that are accelerating the full transition of such technology from the laboratory to clinical applications.
Collapse
Affiliation(s)
- Maria Letizia Terranova
- Dipartimento di Scienze e Tecnologie Chimiche, Università di Roma Tor Vergata, Via della Ricerca Scientifica, 00133 Roma, Italy; or
- Centro di Ricerca Interdipartimentale di Medicina Rigenerativa (CIMER), Università di Roma Tor Vergata, Via della Ricerca Scientifica, 00133 Roma, Italy
| |
Collapse
|
4
|
Zalieckas J, Mondragon IR, Pobedinskas P, Kristoffersen AS, Mohamed-Ahmed S, Gjerde C, Høl PJ, Hallan G, Furnes ON, Cimpan MR, Haenen K, Holst B, Greve MM. Polycrystalline Diamond Coating on Orthopedic Implants: Realization and Role of Surface Topology and Chemistry in Adsorption of Proteins and Cell Proliferation. ACS APPLIED MATERIALS & INTERFACES 2022; 14:44933-44946. [PMID: 36135965 PMCID: PMC9542704 DOI: 10.1021/acsami.2c10121] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Accepted: 09/14/2022] [Indexed: 06/16/2023]
Abstract
Polycrystalline diamond has the potential to improve the osseointegration of orthopedic implants compared to conventional materials such as titanium. However, despite the excellent biocompatibility and superior mechanical properties, the major challenge of using diamond for implants, such as those used for hip arthroplasty, is the limitation of microwave plasma chemical vapor deposition (CVD) techniques to synthesize diamond on complex-shaped objects. Here, for the first time, we demonstrate diamond growth on titanium acetabular shells using the surface wave plasma CVD method. Polycrystalline diamond coatings were synthesized at low temperatures (∼400 °C) on three types of acetabular shells with different surface structures and porosities. We achieved the growth of diamond on highly porous surfaces designed to mimic the structure of the trabecular bone and improve osseointegration. Biocompatibility was investigated on nanocrystalline diamond (NCD) and ultrananocrystalline diamond (UNCD) coatings terminated either with hydrogen or oxygen. To understand the role of diamond surface topology and chemistry in the attachment and proliferation of mammalian cells, we investigated the adsorption of extracellular matrix proteins and monitored the metabolic activity of fibroblasts, osteoblasts, and bone-marrow-derived mesenchymal stem cells (MSCs). The interaction of bovine serum albumin and type I collagen with the diamond surfaces was investigated by confocal fluorescence lifetime imaging microscopy (FLIM). We found that the proliferation of osteogenic cells was better on hydrogen-terminated UNCD than on the oxygen-terminated counterpart. These findings correlated with the behavior of collagen on diamond substrates observed by FLIM. Hydrogen-terminated UNCD provided better adhesion and proliferation of osteogenic cells, compared to titanium, while the growth of fibroblasts was poorest on hydrogen-terminated NCD and MSCs behaved similarly on all tested surfaces. These results open new opportunities for application of diamond coatings on orthopedic implants to further improve bone fixation and osseointegration.
Collapse
Affiliation(s)
- Justas Zalieckas
- Department
of Physics and Technology, University of
Bergen, Allegaten 55, 5007 Bergen, Norway
| | - Ivan R. Mondragon
- Department
for Clinical Dentistry, University of Bergen, Årstadveien 19, 5009 Bergen, Norway
| | - Paulius Pobedinskas
- Institute
for Materials Research (IMO), Hasselt University, Wetenschapspark 1, 3590 Diepenbeek, Belgium
- IMOMEC,
Interuniversity MicroElectronics Center (IMEC) vzw, Wetenschapspark 1, 3590 Diepenbeek, Belgium
| | - Arne S. Kristoffersen
- Department
of Physics and Technology, University of
Bergen, Allegaten 55, 5007 Bergen, Norway
| | - Samih Mohamed-Ahmed
- Department
for Clinical Dentistry, University of Bergen, Årstadveien 19, 5009 Bergen, Norway
| | - Cecilie Gjerde
- Department
for Clinical Dentistry, University of Bergen, Årstadveien 19, 5009 Bergen, Norway
| | - Paul J. Høl
- Department
of Orthopaedic Surgery, Haukeland University
Hospital, Jonas Lies vei 65, 5021 Bergen, Norway
- Department
of Clinical Medicine, University of Bergen, Jonas Lies vei 87, 5021 Bergen, Norway
| | - Geir Hallan
- Department
of Orthopaedic Surgery, Haukeland University
Hospital, Jonas Lies vei 65, 5021 Bergen, Norway
- Department
of Clinical Medicine, University of Bergen, Jonas Lies vei 87, 5021 Bergen, Norway
| | - Ove N. Furnes
- Department
of Orthopaedic Surgery, Haukeland University
Hospital, Jonas Lies vei 65, 5021 Bergen, Norway
- Department
of Clinical Medicine, University of Bergen, Jonas Lies vei 87, 5021 Bergen, Norway
| | - Mihaela Roxana Cimpan
- Department
for Clinical Dentistry, University of Bergen, Årstadveien 19, 5009 Bergen, Norway
| | - Ken Haenen
- Institute
for Materials Research (IMO), Hasselt University, Wetenschapspark 1, 3590 Diepenbeek, Belgium
- IMOMEC,
Interuniversity MicroElectronics Center (IMEC) vzw, Wetenschapspark 1, 3590 Diepenbeek, Belgium
| | - Bodil Holst
- Department
of Physics and Technology, University of
Bergen, Allegaten 55, 5007 Bergen, Norway
| | - Martin M. Greve
- Department
of Physics and Technology, University of
Bergen, Allegaten 55, 5007 Bergen, Norway
| |
Collapse
|